Propolis - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The propolis market size is projected to expand from USD 723.49 million in 2025 and USD 757.82 million in 2026 to USD 945.61 million by 2031, registering a CAGR of 4.53% between 2026 to 2031. This report is Segmented Into Product Type (Capsules, Tablets, Liquids, Creams, and Others), Category (Conventional and Organic), Distribution Channel (Supermarkets/Hypermarkets, Pharmacies and Drugstores, Online Retail Stores, and Other Distribution Channels), and Geography (North America, Europe, Asia-Pacific, South America, and Middle East and Africa). The Market Forecasts are Provided in Terms of Value (USD).

Global Propolis Market Trends and Insights

Rising demand for natural immunity-boosting products

Post-pandemic, consumers have increasingly prioritized preventive health measures. This shift has propelled propolis, once a niche ingredient in apitherapy, into the spotlight as a mainstream immunity supplement. A clinical study in 2025 highlighted the efficacy of Promunel, a standardized propolis extract. Developed by Fytexia and marketed by PLT Health Solutions, the study found a notable 31% decrease in respiratory discomfort over a span of 90 days. Such quantifiable results offer formulators a solid foundation for product claims. However, this finding stands in stark contrast to the European Food Safety Authority's (EFSA) dismissal of health claims associated with propolis, highlighting a clear regulatory divide between the transatlantic regions. While EFSA maintains stringent substantiation standards, North American and Asian markets have been more lenient. As a result, these regions have seamlessly integrated propolis into multivitamin combinations and immune-boosting regimens. The appeal of propolis, especially its polyphenol and flavonoid content like artepillin C found in Brazilian green propolis, is evident. Consumers are increasingly gravitating towards it as a natural alternative to synthetic immunomodulators, even as the scientific community continues to explore the nuances of its dose-response relationships.

Increasing product launches in the functional food space

In 2024 and 2025, the pace of product innovation quickened, introducing a range of offerings from capsules and sprays to liquid concentrates. Life Extension's December 2025 debut of Bee Immune Propolis Capsules, standardized to 12% polyphenols, highlights a trend towards biomarker-driven formulations. In November 2025, Beekeeper's Naturals rolled out its Propolis Throat Soother spray in major retail outlets like Target, Walmart, and Whole Foods, capitalizing on the growing demand for convenient, on-the-go wellness solutions. Vimergy, in July 2024, unveiled its USDA Organic Liquid PropolisPure, boasting 1,220 mg of the PROMUNEL standardized extract in every 2 mL serving. They also adopted a direct-to-consumer subscription model, offering 5% discounts to ensure steady revenue. These product launches indicate a strategic shift from traditional bulk raw propolis to more refined, standardized formats. These new offerings not only command higher prices but also promise consistency in formulation. This evolution aligns with broader trends in the nutraceutical sector, where brands are increasingly emphasizing clinical validation, third-party endorsements, and transparent supply chain stories to set themselves apart.

Allergen concerns limit use among sensitive consumers

Allergic reactions to propolis, ranging from contact dermatitis to severe anaphylaxis, hinder its widespread acceptance in the wellness industry. Caffeic acid phenethyl ester (CAPE), a bioactive compound prevalent in propolis, has been pinpointed as the main allergen triggering these sensitivities. Reports highlight significant skin reactions among beekeepers and consumers using propolis-infused topicals. As a precaution, dermatologists now advocate for patch testing prior to regular application. The challenge of allergenicity is intensified by the diverse compositions of propolis. Varieties sourced from Brazilian green (Baccharis dracunculifolia), red (Dalbergia ecastaphyllum), European poplar, and Pacific Macaranga tanarius each boast unique phytochemical profiles, complicating predictions of cross-reactivity. Lemon Pharma's Apropolis Liquid Spray, exclusively derived from South American poplar, eucalyptus, acacia, and pine, claims to be less allergenic than its European counterparts. This move underscores suppliers' efforts to reduce risk by emphasizing origin differences. Yet, despite these precautions, the lack of standardized allergen-testing methods and the absence of mandatory allergen labeling in numerous regions expose consumers to risks. This vulnerability is especially pronounced in e-commerce platforms, where product details can often be scant.

Other drivers and restraints analyzed in the detailed report include:

• Influencer marketing boosts awareness of propolis benefits
• Propolis recognized as a natural antibiotic alternative globally
• High product prices restrict mass market growth

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Spray and liquid propolis formats are projected to grow at a 5.50% CAGR through 2031, outpacing capsules, which held a 36.62% market share in 2025. This shift is driven by convenience: throat sprays deliver propolis directly to mucous membranes, bypassing first-pass metabolism and providing swift relief for sore throats and oral discomfort. Beekeeper's Naturals Propolis Throat Soother spray, launched in November 2025 at Target, Walmart, and Whole Foods, highlights the category's retail appeal. Lemon Pharma's Apropolis Liquid Spray, with 4% propolis extract sourced from South American botanicals to reduce allergenicity, is gaining traction. Vimergy's USDA Organic Liquid PropolisPure, introduced in July 2024, offers 1,220 mg of PROMUNEL standardized extract per 2 mL serving and uses a direct-to-consumer subscription model with a 5% discount to drive recurring revenue. Capsules remain dominant in the preventive-health segment, where daily dosing consistency outweighs rapid relief. Life Extension's Bee Immune Propolis Capsules, standardized to 12% polyphenols and launched in December 2025, cater to this demand. Tablets and creams serve niche uses, such as chewables for children and topicals for skin conditions, but lack the growth momentum of liquids.

Nanoencapsulation technologies are transforming bioavailability. Propolis flavonoids face less than 10% oral bioavailability due to poor water solubility and rapid hepatic metabolism. Liposomal and nanoemulsion delivery systems improve absorption, supporting premium pricing. Consumer feedback is mixed: 45.7% praised "tasty flavors," while 55.4% cited "unpleasant taste," emphasizing the need for palatability in liquid formats. Brands excelling in taste-masking, through honey blends, essential oils, or flavor encapsulation, are well-positioned to capture the 5.50% CAGR growth in liquid propolis.

Complete Report Scope:

• Product Type
  • Capsules
  • Tablets
  • Liquids
  • Creams
  • Others
• Category
  • Conventional
  • Organic
• Distribution Channel
  • Supermarkets/Hypermarkets
  • Pharmacies and Drugstores
  • Online Retail Stores
  • Other Distribution Channels
• Geography
  • North America
    • United States
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Sweden
    • Belgium
    • Poland
    • Netherlands
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Thailand
    • Singapore
    • South Korea
    • Australia
    • New Zealand
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Middle East and Africa
    • United Arab Emirates
    • Saudi Arabia
    • Qatar
    • Turkey
    • South Africa
    • Nigeria
    • Egypt
    • Morocco
    • Rest of Middle East and Africa

Geography Analysis

Asia-Pacific dominates with a 33.43% market share in 2025 as consumers integrate traditional medicine practices and prioritize health awareness. China leads the regional market, though Comvita experienced a 17.6% revenue decline in Chinese markets during 2024. India targets mass market distribution while Japan focuses on premium segments, creating distinct growth pathways. The region's strong apiculture foundation and cultural acceptance drive market growth, though companies face challenges navigating varied regulations across countries.

South America drives market expansion at a 6.52% CAGR through 2031, with Brazil leading propolis production and processing. Brazilian producers create premium-grade propolis, valued for its unique chemical properties and health benefits. The region strengthens its position through enhanced export capabilities and trade agreements. Argentina offers growth opportunities despite economic challenges affecting market stability. Sustainable production practices and diverse propolis varieties give South American producers a competitive edge.

North America and Europe shape market standards through strict regulations and premium positioning. These regions grow through product innovations and increased market reach. European regulators now require apiculture importers to register in the EU's Trade Control and Expert System, benefiting established companies. North American consumers readily accept premium prices for scientifically-proven products, supported by healthcare professionals. The Middle East and Africa show growth potential as economic development increases, though limited infrastructure and developing regulations currently restrict market expansion.

List of Companies Covered in this Report:

• Comvita Ltd
• Apiary Polenecter
• Apis Flora Industrial e Comercial Ltda
• NOW Foods
• Herb Pharm LLC
• Uniflora Nutraceutica Ltda
• YS Organic Bee Farms
• Sunyata Produtos Alternativos Ltda
• Wax Green
• INW Manufacturing, LLC
• Bio-Botanica Inc.
• SBS Scientific Bio Solutions
• Natura Nectar LLC
• Hong Leong Group
• New Zealand Health Food Co.
• Apiter Laboratories
• Arataki Honey Ltd
• Honey Pacifica Company
• Sunlite India Agro Producer Company Ltd.
• Aravalli Honey Industries

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support